Screener
Cognition Therapeutics, Inc. CGTX Q1 2026 earnings
Reported May 7, 2026 · Before market open
EPS-$0.05Beat by $0.01
Revenue estimate$4.4M
EPS estimate-$0.06
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$5.3M
EPS estimate-$0.07
Versus estimates
Diluted EPS
FAQ
- When did Cognition Therapeutics, Inc. report Q1 2026 earnings?
- Cognition Therapeutics, Inc. (CGTX) reported Q1 2026 earnings on May 7, 2026 before market open.
- What were Cognition Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Cognition Therapeutics, Inc. reported eps of $-0.05 for Q1 2026.
- Did Cognition Therapeutics, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.06 by $0.01.
- How did Cognition Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 64.3% from $-0.14.
- Where can I find Cognition Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-057186) and the 10-Q periodic report (0001104659-26-057545) directly on SEC EDGAR. The filing index links above go to sec.gov.
